Original news and analysis on international IP policy
Par Catherine Saez L’extension des brevets aux organismes génétiquement modifiés (OGM) et leur production dans de nombreux pays menacent les droits des agriculteurs et la biodiversité, la sécurité alimentaire dépendant de plus en plus d’une poignée d’entreprises transnationales de biotechnologie,…
By Nick Wadhams for Intellectual Property Watch NAIROBI, KENYA – Amid fears that huge quantities of counterfeit medicines and pesticides are pouring into Africa, the international law enforcement agency INTERPOL is leading the way to invest more effort and money…
By Kaitlin Mara An avian influenza outbreak would be a public health disaster, but for the World Health Organization to adequately prepare for that risk, member states must come to a resolution on intellectual property issues related to virus and…
Por Catherine Saez Según los oradores de un reciente taller llevado a cabo en Ginebra, debido a la expansión del alcance de las patentes de organismos modificados genéticamente (OMG) y la aplicación de dichos cultivos en la mayoría de los…
By Drew Clark for Intellectual Property Watch WASHINGTON, DC – With major legislative changes to the United States patent system unfinished as the 110th Congress prepares to dissolve, Executive- and Judicial-branch agencies on Friday jostled for authority over future patent…
By Dugie Standeford for Intellectual Property Watch
Before a packed audience, the United States Court of Appeals for the Federal Circuit (CAFC) Friday tackled the highly controversial dispute between the US Patent and Trademark Office (USPTO) and much of the patent bar over rules capping the number of continuation requests and claims patent seekers can submit without incurring additional expenses and paperwork.
By David Cronin for Intellectual Property Watch BRUSSELS – Leading pharmaceutical companies are using the patent system to delay the entry of generic medicines onto the market, the European Commission has alleged, sparking a debate at a conference held here…
[Update from the author: Brazil announced on 19 December adoption of the resolution against the extension of patent rights to second-use drugs and polymorphs. Such patents were seen as subterfuges from the pharmaceutical companies to expand their patent rights. The…
By Kaitlin Mara The World Trade Organization body mandated to discuss a registry for geographical indications met Monday, with the only resulting agreement being to meet again later this week for further, more technical, discussions. Several ambassadors were present at…
By Catherine Saez With the expanding scope of patents on genetically modified organisms (GMOs) and the implementation of such crops in most countries, farmers’ rights and biodiversity are at risk, and food security has become dependent on a few transnational…